Highlights of the Year in JACC 2009.

[1]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. , 2009, Journal of the American College of Cardiology.

[2]  A. Jaffe,et al.  Peripheral blood monocyte subset assessment in non-ST-segment elevation myocardial infarction is required. , 2010, Journal of the American College of Cardiology.

[3]  R. Suri.  Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography , 2010 .

[4]  M. Cheitlin.  Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation , 2010 .

[5]  H. Katus,et al.  Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. , 2009, Journal of the American College of Cardiology.

[6]  M. Sabatine,et al.  Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. , 2009, Journal of the American College of Cardiology.

[7]  A. Colombo,et al.  Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. , 2009, Journal of the American College of Cardiology.

[8]  Angelo B. Biviano,et al.  A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[9]  H. Hecht,et al.  Stent gap by 64-detector computed tomographic angiography relationship to in-stent restenosis, fracture, and overlap failure. , 2009, Journal of the American College of Cardiology.

[10]  Renu Virmani,et al.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. , 2009, Journal of the American College of Cardiology.

[11]  Leif E. Peterson,et al.  The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. , 2009, Journal of the American College of Cardiology.

[12]  M. Robson,et al.  Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. , 2009, Journal of the American College of Cardiology.

[13]  Ian Wilcox,et al.  Obstructive sleep apnea a respiratory syndrome with protean cardiovascular manifestations. , 2009, Journal of the American College of Cardiology.

[14]  Susan Redline,et al.  Triggering of nocturnal arrhythmias by sleep-disordered breathing events. , 2009, Journal of the American College of Cardiology.

[15]  A. Tajik,et al.  High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[16]  Karen A. Hartman,et al.  Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[17]  D. Phelan,et al.  Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. , 2009, Journal of the American College of Cardiology.

[18]  Richard B Devereux,et al.  High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. , 2009, Journal of the American College of Cardiology.

[19]  T. Therneau,et al.  Hospitalizations after heart failure diagnosis a community perspective. , 2009, Journal of the American College of Cardiology.

[20]  M. Seeberger,et al.  Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet? , 2009, Journal of the American College of Cardiology.

[21]  J. Hare,et al.  Tracking cell fate with noninvasive imaging. , 2009, Journal of the American College of Cardiology.

[22]  Y. Makino,et al.  Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning. , 2009, Journal of the American College of Cardiology.

[23]  P. Teirstein,et al.  Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. , 2009, Journal of the American College of Cardiology.

[24]  Jurgen Seidel,et al.  Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. , 2009, Journal of the American College of Cardiology.

[25]  S. Yusuf,et al.  Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. , 2009, Journal of the American College of Cardiology.

[26]  G. Ginsburg,et al.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects. , 2009, Journal of the American College of Cardiology.

[27]  G. Stone,et al.  Left main percutaneous coronary intervention crossing the threshold: time for a guidelines revision! , 2009, Journal of the American College of Cardiology.

[28]  B. Chow,et al.  Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography. , 2009, Journal of the American College of Cardiology.

[29]  M. Tendera,et al.  Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. , 2009, Journal of the American College of Cardiology.

[30]  M. Silberbach,et al.  Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study. , 2009, Journal of the American College of Cardiology.

[31]  G. Stone,et al.  Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2009, Journal of the American College of Cardiology.

[32]  E. Nagel,et al.  EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.

[33]  J. Francis,et al.  The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.

[34]  C. Mueller,et al.  B-type natriuretic peptide in children: step by step... , 2009, Journal of the American College of Cardiology.

[35]  D. Berman,et al.  Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study. , 2009, Journal of the American College of Cardiology.

[36]  H. White,et al.  Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2009, Journal of the American College of Cardiology.

[37]  J. Neuberger,et al.  Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. , 2009, Journal of the American College of Cardiology.

[38]  D. Lloyd‐Jones,et al.  The role of biomarkers and genetics in peripheral arterial disease. , 2009, Journal of the American College of Cardiology.

[39]  C. Lavie,et al.  Beta-blockers as first-line antihypertensive therapy the crumbling continues. , 2009, Journal of the American College of Cardiology.

[40]  J. Hollander.  Highly sensitive troponins the answer or just more questions? , 2009, Journal of the American College of Cardiology.

[41]  P. Insel,et al.  The best "model system" for human (coronary arteries) is human. , 2009, Journal of the American College of Cardiology.

[42]  G. Biondi-Zoccai,et al.  Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). , 2009, Journal of the American College of Cardiology.

[43]  P. Morange,et al.  Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. , 2009, Journal of the American College of Cardiology.

[44]  B. Jensen,et al.  The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries. , 2009, Journal of the American College of Cardiology.

[45]  B. Lindahl,et al.  Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. , 2009, Journal of the American College of Cardiology.

[46]  A. Iskandrian,et al.  Regadenoson: a new myocardial stress agent. , 2009, Journal of the American College of Cardiology.

[47]  Hans Wedel,et al.  Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). , 2009, Journal of the American College of Cardiology.

[48]  P. McCullough,et al.  B-type natriuretic peptide and echocardiography in the surveillance of severe mitral regurgitation prior to valve surgery. , 2009, Journal of the American College of Cardiology.

[49]  V. Hasselblad,et al.  Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[50]  H. Oral,et al.  Amiodarone or dronedarone for atrial fibrillation: too early to know the winner? , 2009, Journal of the American College of Cardiology.

[51]  R. Cury,et al.  Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. , 2009, Journal of the American College of Cardiology.

[52]  M. Mosseri,et al.  Prophylactic pre-operative coronary revascularization: is the Phoenix awakening? , 2009, Journal of the American College of Cardiology.

[53]  J. Burnett,et al.  A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions. , 2009, Journal of the American College of Cardiology.

[54]  P. Pibarot,et al.  Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. , 2009, Journal of the American College of Cardiology.

[55]  G. Ambrosio,et al.  Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. , 2009, Journal of the American College of Cardiology.

[56]  Smadar Cohen,et al.  Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. , 2009, Journal of the American College of Cardiology.

[57]  C. Otto,et al.  Aortic stenosis severity: do we need a new concept? , 2009, Journal of the American College of Cardiology.

[58]  A. J. Bold.  Cardiac Natriuretic Peptides: Gaining Further Insights Into Structure-Function Relationships , 2009 .

[59]  Nico Mollet,et al.  Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. , 2009, Journal of the American College of Cardiology.

[60]  D. O'Connor,et al.  Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. , 2009, Journal of the American College of Cardiology.

[61]  A. Kirtane,et al.  5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. , 2009, Journal of the American College of Cardiology.

[62]  H. Krumholz,et al.  All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. , 2009, Journal of the American College of Cardiology.

[63]  B. Fetics,et al.  Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. , 2009, Journal of the American College of Cardiology.

[64]  K. Shivkumar,et al.  Improving our understanding of epicardial ventricular tachycardia in nonischemic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[65]  E. Kaufman,et al.  Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. , 2009, Journal of the American College of Cardiology.

[66]  M. Horie,et al.  D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. , 2009, Journal of the American College of Cardiology.

[67]  B. Joung,et al.  Autonomic nervous system activity measured directly and QT interval variability in normal and pacing-induced tachycardia heart failure dogs. , 2009, Journal of the American College of Cardiology.

[68]  J. Triedman.  The Meaning of Lethal Events in Infants With Long QT Syndrome. , 2009, Journal of the American College of Cardiology.

[69]  E. Kaufman.  Disease-causing polymorphisms in the spectrum of long QT syndrome mutations. , 2009, Journal of the American College of Cardiology.

[70]  Ó. Cano,et al.  Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[71]  Seung‐Jung Park,et al.  Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgi , 2009, Journal of the American College of Cardiology.

[72]  A. Castellanos,et al.  Indications for implantable cardioverter-defibrillators based on evidence and judgment. , 2009, Journal of the American College of Cardiology.

[73]  Bernet Kato,et al.  Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. , 2009, Journal of the American College of Cardiology.

[74]  E. Antman,et al.  The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis , 2009, Journal of the American College of Cardiology.

[75]  Scott Lim,et al.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. , 2009, Journal of the American College of Cardiology.

[76]  Bryan Williams,et al.  Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate. , 2009, Journal of the American College of Cardiology.

[77]  S. Lafitte.  Do we need new echocardiographic prognosticators for the management of heart failure patients? , 2009, Journal of the American College of Cardiology.

[78]  Dong-Jin Oh,et al.  Global 2-dimensional strain as a new prognosticator in patients with heart failure. , 2009, Journal of the American College of Cardiology.

[79]  D. McPherson,et al.  Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. , 2009, Journal of the American College of Cardiology.

[80]  C. Meyer,et al.  Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. , 2009, Journal of the American College of Cardiology.

[81]  M. Dewey.  Comprehensive assessment of peripheral artery disease using magnetic resonance imaging, angiography, and spectroscopy. , 2009, Journal of the American College of Cardiology.

[82]  G. Marcus,et al.  Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.

[83]  V. Pasceri,et al.  Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. , 2009, Journal of the American College of Cardiology.

[84]  S. Ellis,et al.  Recapturing the magic: revisiting the pleiotropic effects of statins in percutaneous coronary revascularization. , 2009, Journal of the American College of Cardiology.

[85]  S. Narayan,et al.  Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.

[86]  J. Denollet,et al.  Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. , 2009, Journal of the American College of Cardiology.

[87]  H. Schild,et al.  Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. , 2009, Journal of the American College of Cardiology.

[88]  F. Wackers.  Customized exercise testing. , 2009, Journal of the American College of Cardiology.

[89]  Ariel Roguin,et al.  Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. , 2009, Journal of the American College of Cardiology.

[90]  G. Beller,et al.  Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role? , 2009, Journal of the American College of Cardiology.

[91]  U. Elkayam.  Beta-blockers in the treatment of aortic regurgitation a new opportunity? , 2009, Journal of the American College of Cardiology.

[92]  S. Kardia,et al.  Clinical and genetic modifiers of long-term survival in heart failure. , 2009, Journal of the American College of Cardiology.

[93]  A. Opotowsky,et al.  Trends in hospitalizations for adults with congenital heart disease in the U.S. , 2009, Journal of the American College of Cardiology.

[94]  B. Bozkurt,et al.  Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. , 2009, Journal of the American College of Cardiology.

[95]  S. Yusuf,et al.  Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines , 2013 .

[96]  A. Henning,et al.  Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. , 2009, Journal of the American College of Cardiology.

[97]  B. Gersh,et al.  Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2009, Journal of the American College of Cardiology.

[98]  P. Varadarajan,et al.  Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. , 2009, Journal of the American College of Cardiology.

[99]  L. Wallentin,et al.  Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. , 2009, Journal of the American College of Cardiology.

[100]  J. Towbin,et al.  ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. , 2009, Journal of the American College of Cardiology.

[101]  R. Morrison,et al.  Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. , 2009, Journal of the American College of Cardiology.

[102]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[103]  D. Andreini,et al.  Diagnostic accuracy of coronary computed tomography angiography: a comparison between prospective and retrospective electrocardiogram triggering. , 2009, Journal of the American College of Cardiology.

[104]  L. Mestroni.  Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss? , 2009, Journal of the American College of Cardiology.

[105]  J. Towbin,et al.  Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[106]  B. Gersh,et al.  Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. , 2009, Journal of the American College of Cardiology.

[107]  W. Manning,et al.  Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[108]  P. Serruys,et al.  The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. , 2009, Journal of the American College of Cardiology.

[109]  J. Towbin,et al.  Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[110]  Oliver Gaemperli,et al.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.

[111]  G. Lip,et al.  Monocyte diversity in myocardial infarction. , 2009, Journal of the American College of Cardiology.

[112]  C. Grines,et al.  Combining antiplatelet and anticoagulant therapies. , 2009, Journal of the American College of Cardiology.

[113]  A. Kastrati,et al.  The only better alternative to rescue percutaneous coronary intervention is primary percutaneous coronary intervention. , 2009, Journal of the American College of Cardiology.

[114]  S. Rafelt,et al.  Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial. , 2009, Journal of the American College of Cardiology.

[115]  P. Kirchhof,et al.  Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. , 2009, Journal of the American College of Cardiology.

[116]  K. Williams,et al.  Quantification of myocardial flow reserve using positron emission imaging the journey to clinical use. , 2009, Journal of the American College of Cardiology.

[117]  Paul B. Sparks,et al.  Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[118]  T. Akasaka,et al.  Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[119]  E. Braunwald,et al.  The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[120]  T. Marwick.  The deconvolution of diastole. , 2009, Journal of the American College of Cardiology.

[121]  Yu Ting Tan,et al.  The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. , 2009, Journal of the American College of Cardiology.

[122]  Takahiro Higuchi,et al.  Cardiac positron emission tomography. , 2009, Journal of the American College of Cardiology.

[123]  S. Normand,et al.  Cardiac rehabilitation and survival in older coronary patients. , 2009, Journal of the American College of Cardiology.

[124]  N. Morgenthaler,et al.  Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[125]  T. Floyd,et al.  Skeletal muscle microvascular flow in progressive peripheral artery disease: assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[126]  A. Leonard,et al.  Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. , 2009, Journal of the American College of Cardiology.

[127]  G. Schuler,et al.  Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. , 2009, Journal of the American College of Cardiology.

[128]  A. Cohen-Solal,et al.  Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[129]  M. Silberbach.  Bicuspid aortic valve and thoracic aortic aneurysm: toward a unified theory. , 2009, Journal of the American College of Cardiology.

[130]  B. Strauer,et al.  The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[131]  R. Siegel,et al.  Aortopathy is prevalent in relatives of bicuspid aortic valve patients. , 2009, Journal of the American College of Cardiology.

[132]  T. Porter.  Capillary blood flow abnormalities in the skeletal muscle and microvascular complications in diabetes lessons that cannot be learned from larger vessels. , 2009, Journal of the American College of Cardiology.

[133]  S. Kaul,et al.  Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. , 2009, Journal of the American College of Cardiology.

[134]  B. Knight,et al.  The use of intracardiac echocardiography and other intracardiac imaging tools to guide noncoronary cardiac interventions. , 2009, Journal of the American College of Cardiology.

[135]  A. Cohen-Solal,et al.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.

[136]  Z. Fayad,et al.  Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?". , 2009, Journal of the American College of Cardiology.

[137]  Martin J Graves,et al.  The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.

[138]  J. Kaski,et al.  STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone): is the biggest big enough? , 2009, Journal of the American College of Cardiology.

[139]  T. Funahashi,et al.  Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[140]  S. Yusuf,et al.  Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). , 2009, Journal of the American College of Cardiology.

[141]  D. Bluemke,et al.  Will 3.0-T make coronary magnetic resonance angiography competitive with computed tomography angiography? , 2009, Journal of the American College of Cardiology.

[142]  Debiao Li,et al.  Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. , 2009, Journal of the American College of Cardiology.

[143]  J. Peteiro,et al.  Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing. , 2009, Journal of the American College of Cardiology.

[144]  F. Flachskampf,et al.  Stress echocardiography in known or suspected coronary artery disease: an exercise in good clinical practice. , 2009, Journal of the American College of Cardiology.

[145]  M. Yano,et al.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. , 2009, Journal of the American College of Cardiology.

[146]  T. Shannon,et al.  Diastolic release of calcium from the sarcoplasmic reticulum: a potential target for treating triggered arrhythmias and heart failure. , 2009, Journal of the American College of Cardiology.

[147]  Jeroen J. Bax,et al.  Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. , 2009, Journal of the American College of Cardiology.

[148]  J. McMurray,et al.  Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. , 2009, Journal of the American College of Cardiology.

[149]  J. Sanderson.  Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged? , 2009, Journal of the American College of Cardiology.

[150]  J. Ware,et al.  Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2009, Journal of the American College of Cardiology.

[151]  A. Cribier,et al.  Outcomes and safety of percutaneous aortic valve replacement. , 2009, Journal of the American College of Cardiology.

[152]  W. Chung,et al.  Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation. , 2009, Journal of the American College of Cardiology.

[153]  C. Tribouilloy,et al.  Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. , 2009, Journal of the American College of Cardiology.

[154]  P. Bonhoeffer,et al.  Extended application of percutaneous pulmonary valve implantation. , 2009, Journal of the American College of Cardiology.

[155]  R. Ibrahim,et al.  Transcatheter mitral and pulmonary valve therapy. , 2009, Journal of the American College of Cardiology.

[156]  Philippe Pibarot,et al.  Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. , 2009, Journal of the American College of Cardiology.

[157]  F. Alfonso.  Left main coronary artery stenting: crossing the Rubicon. , 2009, Journal of the American College of Cardiology.

[158]  T. Inder,et al.  Pre-operative brain injury in newborn infants with transposition of the great arteries occurs at rates similar to other complex congenital heart disease and is not related to balloon atrial septostomy. , 2009, Journal of the American College of Cardiology.

[159]  K. Margulies,et al.  Genomics, transcriptional profiling, and heart failure. , 2009, Journal of the American College of Cardiology.

[160]  A. Kastrati,et al.  Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. , 2009, Journal of the American College of Cardiology.

[161]  R. Mosca.  Balloon atrial septostomy let's take a closer look. , 2009, Journal of the American College of Cardiology.

[162]  R. Goeree,et al.  Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. , 2009, Journal of the American College of Cardiology.

[163]  George Dangas,et al.  Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. , 2009, Journal of the American College of Cardiology.

[164]  M. Hlatky.  Evaluating use of coronary computed tomography angiography in the emergency department. , 2009, Journal of the American College of Cardiology.

[165]  E. Kim,et al.  A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. , 2009, Journal of the American College of Cardiology.

[166]  Raimund Erbel,et al.  Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. , 2009, Journal of the American College of Cardiology.

[167]  Ole Fröbert,et al.  Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). , 2009, Journal of the American College of Cardiology.

[168]  Fabian Bamberg,et al.  Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. , 2009, Journal of the American College of Cardiology.

[169]  Eric L Eisenstein,et al.  Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. , 2009, Journal of the American College of Cardiology.

[170]  Debiao Li,et al.  Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis). , 2009, Journal of the American College of Cardiology.

[171]  J. Trochu,et al.  Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart. , 2009, Journal of the American College of Cardiology.

[172]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[173]  David S. Hirsh,et al.  Real-time 3-dimensional transesophageal echocardiography in the evaluation of post-operative mitral annuloplasty ring and prosthetic valve dehiscence. , 2009, Journal of the American College of Cardiology.

[174]  F. Verheugt,et al.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.

[175]  P. Dandona,et al.  Acute myocardial infarction, hyperglycemia, and insulin. , 2009, Journal of the American College of Cardiology.

[176]  J. Lindbäck,et al.  Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. , 2009, Journal of the American College of Cardiology.

[177]  Ajit P Yoganathan,et al.  Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. , 2009, Journal of the American College of Cardiology.

[178]  G. Paolisso,et al.  Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.

[179]  Craig A Simmons,et al.  Aortic valve mechanics: an emerging role for the endothelium. , 2009, Journal of the American College of Cardiology.

[180]  J. Mega,et al.  Interaction between cigarette smoking and clinical benefit of clopidogrel. , 2009, Journal of the American College of Cardiology.

[181]  Amy Daly,et al.  Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. , 2009, Journal of the American College of Cardiology.

[182]  James O. Mudd,et al.  Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. , 2009, Journal of the American College of Cardiology.

[183]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2009, The Lancet.

[184]  M. Allessie.  The "second factor": a first step toward diagnosing the substrate of atrial fibrillation? , 2009, Journal of the American College of Cardiology.

[185]  Christopher X. Wong,et al.  Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". , 2009, Journal of the American College of Cardiology.

[186]  F. Klocke.  Emerging applications of T2-weighted cardiac magnetic resonance imaging in acute ischemic syndromes. , 2009, Journal of the American College of Cardiology.

[187]  J. Tyberg,et al.  Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. , 2009, Journal of the American College of Cardiology.

[188]  T. Kolias,et al.  Three-dimensional transesophageal echocardiography of pacemaker endocarditis. , 2009, Journal of the American College of Cardiology.

[189]  J. Balligand.  beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?". , 2009, Journal of the American College of Cardiology.

[190]  高濱 博幸.  Prolonged Targeting of Ischemic/reperfused Myocardium by Liposomal Adenosine Augments Cardioprotection in Rats , 2009 .

[191]  J. D. de Lemos,et al.  Clinical ResearchInterventional CardiologyA Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions: The SOS (Stenting Of Saphenous Vein Grafts) Trial , 2009 .

[192]  David Tepper,et al.  Optimal Left Ventricular Lead Position Predicts Reverse Remodeling and Survival After Cardiac Resynchronization Therapy , 2009 .

[193]  G. V. Van Hare,et al.  Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies. , 2009, Journal of the American College of Cardiology.

[194]  M. Sugimachi,et al.  Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. , 2009, Journal of the American College of Cardiology.

[195]  T. Abraham,et al.  Stress echocardiography: diastole to the rescue. , 2009, Journal of the American College of Cardiology.

[196]  W. Herzog,et al.  Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. , 2009, Journal of the American College of Cardiology.

[197]  F. Crea,et al.  High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. , 2009, Journal of the American College of Cardiology.

[198]  Michael V. Cohen,et al.  Adenosine at reperfusion: a conundrum ready to be resolved. , 2009, Journal of the American College of Cardiology.

[199]  A. Kaltoft,et al.  2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). , 2009, Journal of the American College of Cardiology.

[200]  K. Ishii,et al.  Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning: is it a reliable marker in detecting coronary artery disease? , 2009, Journal of the American College of Cardiology.

[201]  S. Hailpern,et al.  Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. , 2009, Journal of the American College of Cardiology.

[202]  M. Jessup,et al.  The cardiorenal syndrome: do we need a change of strategy or a change of tactics? , 2009, Journal of the American College of Cardiology.

[203]  H. Heidbuchel,et al.  Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. , 2009, Journal of the American College of Cardiology.

[204]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[205]  P. Doevendans,et al.  Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. , 2009, Journal of the American College of Cardiology.

[206]  Jeroen J. Bax,et al.  Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. , 2009, Journal of the American College of Cardiology.

[207]  M. Marber,et al.  Lizard spit and reperfusion injury. , 2009, Journal of the American College of Cardiology.

[208]  T. Graham,et al.  The dilated aorta in patients with congenital cardiac defects. , 2009, Journal of the American College of Cardiology.

[209]  D. Shera,et al.  Preoperative Brain Injury in Transposition of the Great Arteries Is Associated With Oxygenation and Time to Surgery, Not Balloon Atrial Septostomy , 2009, Circulation.

[210]  B. Williams.  The aorta and resistant hypertension. , 2009, Journal of the American College of Cardiology.

[211]  H. Schelbert.  Coronary circulatory function abnormalities in insulin resistance: insights from positron emission tomography. , 2009, Journal of the American College of Cardiology.

[212]  Takashi Morita,et al.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.

[213]  J. Blacher,et al.  Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. , 2009, Journal of the American College of Cardiology.

[214]  F. Schiele,et al.  Are you as old as your arteries or as old as your coronary artery calcification score? , 2009, Journal of the American College of Cardiology.

[215]  R. Kronmal,et al.  Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). , 2009, Journal of the American College of Cardiology.

[216]  S. Mulvagh,et al.  Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. , 2009, Journal of the American College of Cardiology.

[217]  S. Colan,et al.  A Cross-Sectional Study of Exercise Performance During the First 2 Decades of Life After the Fontan Operation , 2009 .

[218]  M. Cheitlin.  Antiarrhythmic Effect of Reverse Ventricular Remodeling Induced by Cardiac Resynchronization Therapy: The InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry , 2009 .

[219]  B. Gersh.  Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients , 2009 .

[220]  岡田 正穂.  Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium , 2009 .

[221]  J. Saffitz.  Expanding the spectrum of arrhythmogenic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[222]  M. Hibberd,et al.  Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). , 2008, The American journal of cardiology.

[223]  P. Menasché.  Skeletal myoblasts for cardiac repair: Act II? , 2008, Journal of the American College of Cardiology.

[224]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[225]  T. Münzel,et al.  NOX5, a new "radical" player in human atherosclerosis? , 2008, Journal of the American College of Cardiology.

[226]  N. Trayanova,et al.  Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. , 2008, Journal of the American College of Cardiology.

[227]  K. Swedberg,et al.  Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.

[228]  Joseph C. Wu.  Molecular imaging: antidote to cardiac stem cell controversy. , 2008, Journal of the American College of Cardiology.

[229]  R. Wahl,et al.  Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. , 2008, Journal of the American College of Cardiology.

[230]  A. Íñiguez,et al.  Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. , 2008, Journal of the American College of Cardiology.

[231]  P. Poole‐Wilson.  Global differences in the outcome of heart failure: implications for clinical practice. , 2008, Journal of the American College of Cardiology.

[232]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[233]  E. Agapitos,et al.  Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[234]  Sanjiv Kaul,et al.  Myocardial capillaries and coronary flow reserve. , 2008, Journal of the American College of Cardiology.

[235]  T. Marwick,et al.  The riddle of determining cardiac resynchronization therapy response a physiologic approach to dyssynchrony therapy. , 2008, Journal of the American College of Cardiology.

[236]  Federico Lombardi,et al.  Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. , 2008, Journal of the American College of Cardiology.

[237]  Ioannis Kakadiaris,et al.  Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. , 2008, Journal of the American College of Cardiology.

[238]  S. Achenbach.  Assessing the prognostic value of coronary computed tomography angiography. , 2008, Journal of the American College of Cardiology.

[239]  S. Viskin,et al.  J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. , 2008, Journal of the American College of Cardiology.

[240]  C. Terkelsen,et al.  Is there any time left for primary percutaneous coronary intervention according to the 2007 updated American College of Cardiology/American Heart Association ST-segment elevation myocardial infarction guidelines and the D2B alliance? , 2008, Journal of the American College of Cardiology.

[241]  E. Antman.  Time is muscle: translation into practice. , 2008, Journal of the American College of Cardiology.

[242]  Wouter-Jan Rappel,et al.  Repolarization and Activation Restitution near Human Pulmonary Veins and Atrial Fibrillation Initiation a Mechanism for the Initiation of Atrial Fibrillation by Premature Beats , 2022 .

[243]  M. Josephson,et al.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. , 2008, Journal of the American College of Cardiology.

[244]  A. Epstein.  Benefits of the implantable cardioverter-defibrillator. , 2008, Journal of the American College of Cardiology.

[245]  A. DeMaria,et al.  Low LDL-C levels and cancer reassuring but still not definitive. , 2008, Journal of the American College of Cardiology.

[246]  G. Patti,et al.  Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. , 2008, Journal of the American College of Cardiology.

[247]  M. Zwahlen,et al.  Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. , 2008, Journal of the American College of Cardiology.

[248]  T. Trikalinos,et al.  Statins, low-density lipoprotein cholesterol, and risk of cancer. , 2008, Journal of the American College of Cardiology.

[249]  D. Steinberg.  Statin treatment does not cause cancer. , 2008, Journal of the American College of Cardiology.

[250]  Deepak L. Bhatt,et al.  Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. , 2008, Journal of the American College of Cardiology.

[251]  M. Fowler.  Hypertension, heart failure, and beta-adrenergic blocking drugs. , 2008, Journal of the American College of Cardiology.

[252]  S. Bangalore,et al.  Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis. , 2008, Journal of the American College of Cardiology.

[253]  Hanno Pijl,et al.  Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. , 2008, Journal of the American College of Cardiology.

[254]  Gianni Tognoni,et al.  Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). , 2008, Journal of the American College of Cardiology.

[255]  R. Giugliano,et al.  Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. , 2008, Journal of the American College of Cardiology.

[256]  J. Jukema,et al.  Aggressive therapy is not always the best therapy. , 2008, Journal of the American College of Cardiology.

[257]  E. Blackstone,et al.  Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. , 2008, Journal of the American College of Cardiology.

[258]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[259]  A. Cohen,et al.  Atherosclerosis of the thoracic aorta further characterization for higher risk of vascular events. , 2008, Journal of the American College of Cardiology.

[260]  R. Brooks,et al.  Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. , 2008, Journal of the American College of Cardiology.

[261]  D. Towler.  Oxidation, inflammation, and aortic valve calcification peroxide paves an osteogenic path. , 2008, Journal of the American College of Cardiology.

[262]  S. Pocock,et al.  Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2008, Journal of the American College of Cardiology.

[263]  H. Taegtmeyer,et al.  Virchow's metamorphosis revealed triglycerides in the heart. , 2008, Journal of the American College of Cardiology.

[264]  R. Sacco,et al.  Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. , 2008, Journal of the American College of Cardiology.

[265]  F. Neumann,et al.  Aspirin resistance an underestimated risk in patients with drug-eluting stents? , 2008, Journal of the American College of Cardiology.

[266]  B. Carabello.  Aortic stenosis: it is a hot topic the link to coronary artery disease. , 2008, Journal of the American College of Cardiology.

[267]  M. Yacoub,et al.  In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans. , 2008, Journal of the American College of Cardiology.

[268]  A. Gori,et al.  Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. , 2008, Journal of the American College of Cardiology.

[269]  I. Seong,et al.  A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[270]  C. Ballantyne,et al.  Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. , 2008, Journal of the American College of Cardiology.

[271]  Patrick W Serruys,et al.  Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. , 2008, Journal of the American College of Cardiology.

[272]  Y. Henkin.  Re-evaluating therapeutic target goals for statin-treated patients: time for revolutionary changes? , 2008, Journal of the American College of Cardiology.

[273]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[274]  D. Mark,et al.  No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). , 2008, Journal of the American College of Cardiology.

[275]  B. Baker,et al.  The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. , 2008, Journal of the American College of Cardiology.

[276]  N. Reichek,et al.  Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm. , 2008, Journal of the American College of Cardiology.

[277]  A. Curtis.  Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough? , 2008, Journal of the American College of Cardiology.

[278]  L. Kuller,et al.  Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. , 2008, Journal of the American College of Cardiology.

[279]  W. Harris.  Omega-3 fatty acids: the "Japanese" factor? , 2008, Journal of the American College of Cardiology.

[280]  N. Freemantle,et al.  Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. , 2008, Journal of the American College of Cardiology.

[281]  A. Iskandrian,et al.  The effects of medications on myocardial perfusion. , 2008, Journal of the American College of Cardiology.

[282]  D. Hodge,et al.  Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. , 2008, Journal of the American College of Cardiology.

[283]  D. Kraitchman,et al.  Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[284]  Scott H. Settlemier,et al.  Live 3-dimensional transesophageal echocardiography initial experience using the fully-sampled matrix array probe. , 2008, Journal of the American College of Cardiology.

[285]  J. Cooke.  Critical determinants of limb ischemia. , 2008, Journal of the American College of Cardiology.

[286]  J. J. Rivera,et al.  Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. , 2008, Journal of the American College of Cardiology.

[287]  P. Vardas,et al.  Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. , 2008, Journal of the American College of Cardiology.

[288]  G. Fonarow,et al.  Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. , 2008, Journal of the American College of Cardiology.

[289]  R. Starling,et al.  Sodium nitroprusside for advanced low-output heart failure. , 2008, Journal of the American College of Cardiology.

[290]  Roberto Chiesa,et al.  Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. , 2008, Journal of the American College of Cardiology.

[291]  Jeroen J. Bax,et al.  Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. , 2008, Journal of the American College of Cardiology.

[292]  C. Backer.  The Fontan procedure our Odyssey continues. , 2008, Journal of the American College of Cardiology.

[293]  Tal Geva,et al.  Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. , 2008, Journal of the American College of Cardiology.

[294]  G. Marx,et al.  Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory response to exercise. , 2008, Journal of the American College of Cardiology.

[295]  P. Ridker,et al.  Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. , 2008, Journal of the American College of Cardiology.

[296]  G. Francis.  From B-type natriuretic peptide to green mambas: the process of discovery. , 2008, Journal of the American College of Cardiology.

[297]  L. Berglund,et al.  Role of lipoprotein(a) in cardiovascular disease current and future perspectives. , 2008, Journal of the American College of Cardiology.

[298]  Bernd J Pichler,et al.  Radionuclide imaging: a molecular key to the atherosclerotic plaque. , 2008, Journal of the American College of Cardiology.

[299]  Leslee J Shaw,et al.  Coronary artery calcium to predict all-cause mortality in elderly men and women. , 2008, Journal of the American College of Cardiology.

[300]  J. Burnett,et al.  Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. , 2008, Journal of the American College of Cardiology.

[301]  F. Pigula,et al.  Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. , 2008, Journal of the American College of Cardiology.

[302]  Katherine C. Wu,et al.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[303]  J. Mega,et al.  Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[304]  J. Goetze.  Markers of activated coagulation in acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[305]  T. Inomata,et al.  Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. , 2008, Journal of the American College of Cardiology.

[306]  G. Filippatos,et al.  Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. , 2008, Journal of the American College of Cardiology.

[307]  I. Liu,et al.  Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. , 2008, Journal of the American College of Cardiology.

[308]  Seung‐Hyuk Choi,et al.  The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents. , 2008, Journal of the American College of Cardiology.

[309]  J. Kobashigawa,et al.  Supraventricular tachycardia after orthotopic cardiac transplantation. , 2008, Journal of the American College of Cardiology.

[310]  C. Rochitte.  Microvascular obstruction the final frontier for a complete myocardial reperfusion. , 2008, Journal of the American College of Cardiology.

[311]  I. Palacios,et al.  Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease The DELFT ( Drug Eluting stent for LeFT main ) Registry , 2008 .

[312]  J. Tijssen,et al.  Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. , 2008, Journal of the American College of Cardiology.

[313]  W. Peacock.  Will SCUBE1 solve the ischemia marker deficit? , 2008, Journal of the American College of Cardiology.

[314]  T. Rassaf,et al.  Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. , 2008, Journal of the American College of Cardiology.

[315]  J. Panza,et al.  Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes? , 2008, Journal of the American College of Cardiology.

[316]  Daniel Steven,et al.  Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. , 2008, Journal of the American College of Cardiology.

[317]  R. Kloner.  Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient. , 2008, Journal of the American College of Cardiology.

[318]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[319]  C. Gazzaruso,et al.  Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.

[320]  H. Bøtker,et al.  Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. , 2008, Journal of the American College of Cardiology.

[321]  E. Antman,et al.  Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. , 2008, Journal of the American College of Cardiology.

[322]  A. Kong,et al.  Erectile dysfunction predicts coronary heart disease in type 2 diabetes. , 2008, Journal of the American College of Cardiology.

[323]  M. Fromm,et al.  Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.

[324]  Andrew E. Arai,et al.  Aortic valve disease in Turner syndrome. , 2008, Journal of the American College of Cardiology.

[325]  Thomas Lavergne,et al.  Sudden cardiac arrest associated with early repolarization. , 2008, The New England journal of medicine.

[326]  B. Desjardins,et al.  Post-infarction ventricular arrhythmias originating in papillary muscles. , 2008, Journal of the American College of Cardiology.

[327]  S. Glantz,et al.  Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. , 2008, Journal of the American College of Cardiology.

[328]  J. Goldberger,et al.  Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. , 2008, Journal of the American College of Cardiology.

[329]  W. Koenig.  Treating residual cardiovascular risk: will lipoprotein-associated phospholipase A2 inhibition live up to its promise? , 2008, Journal of the American College of Cardiology.

[330]  M. Hanefeld,et al.  The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. , 2008, Journal of the American College of Cardiology.

[331]  Philippe Pibarot,et al.  Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. , 2008, Journal of the American College of Cardiology.

[332]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[333]  P. D. del Nido,et al.  Patch closure of muscular ventricular septal defects with a new hybrid therapy in a pig model. , 2008, Journal of the American College of Cardiology.

[334]  J. Loscalzo,et al.  Lipid levels after acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[335]  J. Wildberger,et al.  Myocardial deformation imaging based on ultrasonic pixel tracking to identify reversible myocardial dysfunction. , 2008, Journal of the American College of Cardiology.

[336]  J. Kastrup,et al.  Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. , 2008, Journal of the American College of Cardiology.

[337]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[338]  B. Jugdutt,et al.  Aging and defective healing, adverse remodeling, and blunted post-conditioning in the reperfused wounded heart. , 2008, Journal of the American College of Cardiology.

[339]  C. Darling,et al.  Aging mouse hearts are refractory to infarct size reduction with post-conditioning. , 2008, Journal of the American College of Cardiology.

[340]  G. Taffet,et al.  Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. , 2008, Journal of the American College of Cardiology.

[341]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[342]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[343]  W. Boden,et al.  Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention. , 2008, Journal of the American College of Cardiology.

[344]  R. Bonow.  Is appropriateness appropriate? , 2008, Journal of the American College of Cardiology.

[345]  J. Avorn,et al.  Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. , 2008, Journal of the American College of Cardiology.

[346]  George A. Johnson,et al.  Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. , 2008, Journal of the American College of Cardiology.

[347]  R. Gibbons,et al.  Application of appropriateness criteria to stress single-photon emission computed tomography sestamibi studies and stress echocardiograms in an academic medical center. , 2008, Journal of the American College of Cardiology.

[348]  S. Dudley,et al.  An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration. , 2008, Journal of the American College of Cardiology.

[349]  J. Tardif,et al.  Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study. , 2008, Journal of the American College of Cardiology.

[350]  B. G. Brown,et al.  ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[351]  Gemma Vilahur,et al.  Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. , 2008, Journal of the American College of Cardiology.

[352]  Josepa Mauri,et al.  Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). , 2008, Journal of the American College of Cardiology.

[353]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[354]  Prashanthan Sanders,et al.  Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. , 2008, Journal of the American College of Cardiology.

[355]  C. Yuan,et al.  Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. , 2008, Journal of the American College of Cardiology.

[356]  P. Schwartz,et al.  Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. , 2008, Journal of the American College of Cardiology.

[357]  R. Lazzara.  The congenital long QT syndrome: a mask for many faces. , 2008, Journal of the American College of Cardiology.

[358]  E. Gerstenfeld.  Functional block in the posterior left atrium another piece in the puzzle of atrial fibrillation initiation. , 2008, Journal of the American College of Cardiology.

[359]  G. Lip,et al.  Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.

[360]  W. Weintraub.  Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[361]  D. Singer,et al.  Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[362]  J. Halperin,et al.  "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. , 2008, Journal of the American College of Cardiology.

[363]  S. Hohnloser,et al.  Atrial-selective approaches for the treatment of atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[364]  Philippe Pibarot,et al.  Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[365]  Tachapong Ngarmukos,et al.  Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[366]  James B. Seward,et al.  Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. , 2008, Journal of the American College of Cardiology.

[367]  K. Katada,et al.  Noninvasive coronary angiography with a prototype 256-row area detector computed tomography system: comparison with conventional invasive coronary angiography. , 2008, Journal of the American College of Cardiology.

[368]  A. Kastrati,et al.  Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[369]  H. Dauerman.  Percutaneous coronary intervention pharmacology: from a triangle to a square. , 2008, Journal of the American College of Cardiology.

[370]  J. Genest.  The Yin and Yang of high-density lipoprotein cholesterol. , 2008, Journal of the American College of Cardiology.

[371]  Craig J. Hartley,et al.  A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. , 2008, Journal of the American College of Cardiology.

[372]  Christina Lindahl,et al.  High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. , 2008, Journal of the American College of Cardiology.

[373]  H. Putter,et al.  Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. , 2008, Journal of the American College of Cardiology.

[374]  J. Herlitz,et al.  Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[375]  W. Levy.  Anemia in heart failure: marker or mediator of adverse prognosis? , 2008, Journal of the American College of Cardiology.

[376]  F. Fedele,et al.  The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. , 2008, Journal of the American College of Cardiology.

[377]  A. Carter,et al.  The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. , 2008, Journal of the American College of Cardiology.

[378]  D. Dudek,et al.  Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.

[379]  Anil K. Jain,et al.  Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. , 2008, Journal of the American College of Cardiology.

[380]  R. Beyar.  Heart inefficiency in pulmonary hypertension: a double jeopardy. , 2008, Journal of the American College of Cardiology.

[381]  W. Little,et al.  "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. , 2008, Journal of the American College of Cardiology.

[382]  R. Levine,et al.  Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. , 2008, Journal of the American College of Cardiology.

[383]  W. Gray,et al.  Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. , 2008, Journal of the American College of Cardiology.

[384]  Filippo Crea,et al.  Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. , 2008, Journal of the American College of Cardiology.

[385]  S. Mittal.  Selecting patients for an implantable cardioverter-defibrillator: can the genie be put back into the bottle? , 2008, Journal of the American College of Cardiology.

[386]  A. Jaffe,et al.  Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.

[387]  Dominique Mottier,et al.  Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.

[388]  A. Moss,et al.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.

[389]  Louis Labrousse,et al.  Experimental validation of circumferential, longitudinal, and radial 2-dimensional strain during dobutamine stress echocardiography in ischemic conditions. , 2008, Journal of the American College of Cardiology.

[390]  R. Barst,et al.  Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. , 2008, Journal of the American College of Cardiology.

[391]  Jeroen J. Bax,et al.  Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at mid-term follow-up , 2008 .

[392]  G. V. van Arsdell.  Can we modify late functional outcome in Ebstein anomaly by altering surgical strategy? , 2008, Journal of the American College of Cardiology.

[393]  Russell Steele,et al.  Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. , 2008, Journal of the American College of Cardiology.

[394]  D. Rosenbaum,et al.  Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling. , 2008, Journal of molecular and cellular cardiology.

[395]  K. Channon,et al.  Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[396]  S. Kaul,et al.  Prevention and treatment: a tale of two strategies. , 2008, Journal of the American College of Cardiology.

[397]  L. Hornberger,et al.  New insights into fetal atrioventricular block using fetal magnetocardiography. , 2008, Journal of the American College of Cardiology.

[398]  M. Fromm,et al.  Cytochrome P 450 2 C 19 681 G > A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents , 2008 .

[399]  S. Pocock,et al.  Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. , 2008, Journal of the American College of Cardiology.

[400]  R. Wakai,et al.  Electrophysiological characteristics of fetal atrioventricular block. , 2008, Journal of the American College of Cardiology.

[401]  Jeremy N Ruskin,et al.  Prophylactic catheter ablation for the prevention of defibrillator therapy. , 2007, The New England journal of medicine.

[402]  H. Dietz,et al.  Familial thoracic aortic dilation and bicommissural aortic valve: A prospective analysis of natural history and inheritance , 2007, American journal of medical genetics. Part A.

[403]  A. DeMaria,et al.  Low-density lipoprotein reduction and cancer: not definitive but provocative. , 2007, Journal of the American College of Cardiology.

[404]  R. Karas,et al.  Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. , 2007, Journal of the American College of Cardiology.

[405]  T. Cheng.  That balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries is another powerful argument in favor of therapeutic closure of every patent foramen ovale. , 2006, The American journal of cardiology.

[406]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[407]  M. Schalij,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. , 2006, Heart rhythm.

[408]  Steven P. Miller,et al.  Balloon Atrial Septostomy Is Associated With Preoperative Stroke in Neonates With Transposition of the Great Arteries , 2006, Circulation.

[409]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[410]  G. Breithardt,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy , 2005, Herz Kardiovaskuläre Erkrankungen.

[411]  A. Moss,et al.  QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. , 2004, Journal of the American College of Cardiology.

[412]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[413]  J. Gulcher,et al.  Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. , 2002, American journal of human genetics.

[414]  S. Higgins,et al.  Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. , 2000, Journal of the American College of Cardiology.

[415]  F. Morady,et al.  Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[416]  A. Camm,et al.  Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction , 1999, The Lancet.

[417]  W. Allan,et al.  Long QT Syndrome , 1998, Pediatrics.

[418]  M. Allessie,et al.  Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. , 1997, Circulation.